Arctoris and Evariste Technologies form a Joint Venture to Identify Novel Small Molecule cMET Inhibitors for Non-Small Cell Lung Cancer

Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC). The partnership brings together two highly synergistic approaches for AI-guided and robotics-powered molecule design, to significantly accelerate the DMTA (Design, Make, Test, Analyze) cycle. Oxford and London – Arctoris, a tech-enabled biopharma company, and […]